Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Centessa Pharmaceuticals (CNTA) Tax Provisions: 2021-2024

Historic Tax Provisions for Centessa Pharmaceuticals (CNTA) over the last 4 years, with Dec 2024 value amounting to $2.8 million.

  • Centessa Pharmaceuticals' Tax Provisions fell 72.70% to $166,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.4 million, marking a year-over-year increase of 15.42%. This contributed to the annual value of $2.8 million for FY2024, which is 111.35% up from last year.
  • Per Centessa Pharmaceuticals' latest filing, its Tax Provisions stood at $2.8 million for FY2024, which was up 111.35% from -$25.1 million recorded in FY2023.
  • In the past 5 years, Centessa Pharmaceuticals' Tax Provisions ranged from a high of $2.8 million in FY2024 and a low of -$25.1 million during FY2023.
  • In the last 3 years, Centessa Pharmaceuticals' Tax Provisions had a median value of -$747,000 in 2022 and averaged -$7.7 million.
  • Its Tax Provisions has fluctuated over the past 5 years, first slumped by 3,254.22% in 2023, then surged by 111.35% in 2024.
  • Yearly analysis of 4 years shows Centessa Pharmaceuticals' Tax Provisions stood at $114,000 in 2021, then plummeted by 755.26% to -$747,000 in 2022, then plummeted by 3,254.22% to -$25.1 million in 2023, then soared by 111.35% to $2.8 million in 2024.